Biomarker-driven clinical research.
We are the world’s most comprehensive services organization for biomarker-driven therapeutic and diagnostic development.
Global Clinical Trials Gt Robust global reach with > 1,000 global clinical trial team Full-service, biomarker-driven trials for emerging and midstage biotech Seamless integration of specialty assays and complex biomarker data informatics EXPLORE
Global Specimen Logistics & Storage Gs Consistent real-time tissue processing in 55 countries Full trial support - kitting, logistics, real-time tracking and storage Over 25 million samples stored in all conditions, globally EXPLORE
Global Biomarker Assays Bm Full portfolio of specialty assays spanning DNA, RNA, protein, cell, and tissue Custom research to full-scale validation including CAP, CLIA, ISO Global footprint to deliver real-time assays EXPLORE
Biospecimens B Fully characterized healthy and disease-state tissue and fluids for research and assay controls Custom isolations for client specific needs EXPLORE
QuartzBioSM Translational Informatics Ti Harmonize biomarker data from multiple labs and EDC Deep multiomic visualization and analysis expertise AI-derived multiomic signatures across data sets EXPLORE
Companion Diagnostics CDx Expert regulatory strategy development and execution Clinical utility and evidence for market access 100+ IVD pre-submissions and 250+ marketing clearances and approvals globally EXPLORE
Therapeutic Expertise Te
Oncology & Immuno-Oncology Io Executed over 350 oncology trials worldwide over 20 years Global Oncology Site Network for rapid study start up Dedicated oncology clinical trials team with > 10 years of experience on average EXPLORE
Neurology N De-risked drug development with precision medicine approaches Integrated regulatory, study design, site, and patient engagement strategy for rare neurological clinical trials EXPLORE
Autoimmune A Global immune monitoring solutions for any phase Novel immune assessment platform–EpiontisID–optimized for autoimmune indications Insights into complex disease biology through translational informatics and pathway analysis EXPLORE
Rare Disease R Maximized recruitment and retention with patient-centric approach Experience in executing over 50 rare disease indications Awarded “Best Orphan Drug CRO” for multiple consecutive years EXPLORE
Gene Therapy Gt Industry-leading expertise in AAV-based assay support from preclinical to full commercial use Excellence in trial design and execution; 100% data submission acceptance CDX development and commercialization for gene therapies EXPLORE
Biopharma Bp Full-service, biomarker-driven trials, commited to emerging and midstage biotech Specialty lab and biomarker informatics for any drug development application Team of 1,000 globally to delivering P1-P3 trials EXPLORE
Biomarker Capabilities Bc
Immune Monitoring Im Advanced assay solutions for complex science, logistics and costs effectiveness Globally redundant infrastructure Assay design that addresses science, logistics and cost EXPLORE
Tissue Biopsy Tp Full-service IHC infrastructure, including centralized pathology Multiplexed quantitative ImmunoFluorescence via Vectra Polaris Validated and custom multiplex panels EXPLORE
QuartzBioSM Qb Harmonize biomarker data from multiple labs and EDC Deep multiomic visualization and analysis expertise AI-derived multiomic signatures across data sets EXPLORE
Large Molecule Bioanalysis Ba Global experts in immune assessments and immunogenicity Comprehensive analytical support for complex biologics – bispecifics, ADCs, and gene therapy EXPLORE
Liquid Biopsy Lb Capture CTCs / cell-free DNA, and prepare cells for downstream assays of any type utilizing Apostream - a proprietary cell separation and enrichment platform Phenotype rare cells Analyze multiple genomic biomarkers EXPLORE
We are the world’s most comprehensive services organization for
biomarker-driven therapeutic and diagnostic development.
August 6, 2019
Precision for Medicine Receives CIR (French Research Tax Credit) AccreditationRead more...
August 1, 2019
Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLASDiscover more...
July 16, 2019
QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston OfficeGet the story...